ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease
Journal of Nephrology
◽
10.5301/jn.2011.6383
◽
2011
◽
Vol 24
(6)
◽
pp. 756-763
◽
Cited By ~ 4
Author(s):
Yasuhiko Tomino
◽
Yoshio Shimizu
◽
Chieko Hamada
◽
Atsushi Kurusu
◽
Isao Ohsawa
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Elderly Patients
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Antiproteinuric Effect
◽
One Year
Download Full-text
Related Documents
Cited By
References
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis
Nephron
◽
10.1159/000508100
◽
2020
◽
Vol 144
(8)
◽
pp. 372-382
◽
Cited By ~ 1
Author(s):
Tadao Akizawa
◽
Yusuke Yamaguchi
◽
Tetsuro Otsuka
◽
Michael Reusch
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
◽
Oral Dosing
Download Full-text
Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan
Therapeutic Apheresis and Dialysis
◽
10.1111/1744-9987.13611
◽
2020
◽
Author(s):
Masaomi Nangaku
◽
Kazuoki Kondo
◽
Souichirou Takabe
◽
Kiichiro Ueta
◽
Genki Kaneko
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Peritoneal Dialysis
◽
Kidney Disease
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
Download Full-text
The evaluation of denosumab safety in patients with chronic kidney disease: An open-label study.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.e20649
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. e20649-e20649
Author(s):
Geoffrey Block
◽
Ogo Egbuna
◽
Steven Zeig
◽
Pablo E. Pergola
◽
Bhupinder Singh
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
15 REDUX: A Multicenter, Open-label Study of DM199 (Recombinant Human Tissue Kallikrein-1) in Patients With Stage II or III Chronic Kidney Disease
American Journal of Kidney Diseases
◽
10.1053/j.ajkd.2021.02.020
◽
2021
◽
Vol 77
(4)
◽
pp. 571
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Human Tissue
◽
Stage Ii
◽
Tissue Kallikrein
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study
BMC Nephrology
◽
10.1186/s12882-020-01971-x
◽
2020
◽
Vol 21
(1)
◽
Author(s):
Seok-hyung Kim
◽
Jong Hyun Jhee
◽
Hoon Young Choi
◽
Sang-Ho Lee
◽
Sug Kyun Shin
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Carbon Adsorbent
◽
Indoxyl Sulfate
◽
Open Label
◽
Advanced Chronic Kidney Disease
◽
Open Label Study
◽
Label Study
◽
Spherical Carbon
Download Full-text
55: A Randomized, Parallel, Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day With Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Chronic Kidney Disease Patients on Hemodialysis
American Journal of Kidney Diseases
◽
10.1053/j.ajkd.2009.01.076
◽
2009
◽
Vol 53
(4)
◽
pp. B36
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Sevelamer Hydrochloride
◽
Sevelamer Carbonate
Download Full-text
25 Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of DM199 in Subjects with Diabetes and Chronic Kidney Disease
American Journal of Kidney Diseases
◽
10.1053/j.ajkd.2020.02.027
◽
2020
◽
Vol 75
(4)
◽
pp. 542-543
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis
Journal of Internal Medicine
◽
10.1111/j.1365-2796.2006.01723.x
◽
2006
◽
Vol 260
(6)
◽
pp. 577-585
◽
Cited By ~ 29
Author(s):
A. K. AGARWAL
◽
M. R. SILVER
◽
J. E. REED
◽
R. K. DHINGRA
◽
W. LIU
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Darbepoetin Alfa
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study
Therapeutic Apheresis and Dialysis
◽
10.1111/1744-9987.12888
◽
2019
◽
Vol 24
(2)
◽
pp. 115-125
◽
Cited By ~ 11
Author(s):
Tadao Akizawa
◽
Tetsuro Otsuka
◽
Michael Reusch
◽
Mai Ueno
Keyword(s):
Chronic Kidney Disease
◽
Peritoneal Dialysis
◽
Kidney Disease
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
◽
Oral Dosing
Download Full-text
Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study
Clinical and Experimental Nephrology
◽
10.1007/s10157-014-1044-4
◽
2014
◽
Vol 19
(4)
◽
pp. 631-638
◽
Cited By ~ 2
Author(s):
Kotaro Soji
◽
Shigehiro Doi
◽
Ayumu Nakashima
◽
Kensuke Sasaki
◽
Toru Kawai
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Angiotensin Ii
◽
Kidney Disease
◽
Receptor Blocker
◽
Angiotensin Ii Receptor Blocker
◽
Advanced Stage
◽
Angiotensin Ii Receptor
◽
Open Label
◽
Open Label Study
◽
Label Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close